These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11173053)

  • 1. Mixed pharmacokinetic population study and diffusion model to describe ciprofloxacin lung concentrations.
    Breilh D; Saux MC; Maire P; Vergnaud JM; Jelliffe RW
    Comput Biol Med; 2001 May; 31(3):147-55. PubMed ID: 11173053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic population study to describe cefepime lung concentrations.
    Breilh D; Saux MC; Delaisement C; Fratta A; Ducint D; Velly JF; Couraud L
    Pulm Pharmacol Ther; 2001; 14(2):69-74. PubMed ID: 11273786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
    Schaefer HG; Stass H; Wedgwood J; Hampel B; Fischer C; Kuhlmann J; Schaad UB
    Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous pharmacokinetics of ciprofloxacin in goats.
    García Ovando H; Gorla N; Poloni G; Trotti N; Prieto G; Errecalde C
    Int J Antimicrob Agents; 2000 Jun; 15(1):77-9. PubMed ID: 10856681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population pharmacokinetic study of alminoprofen penetration into synovial fluid.
    Tod M; Pobel C; Le Gros V; Louchahi K; Petitjean O; Brion N; Garcia-Mace JL
    Biopharm Drug Dispos; 1995 Nov; 16(8):627-34. PubMed ID: 8573683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population pharmacokinetic-metabolism model for individualizing ciprofloxacin therapy in ophthalmology.
    Di Marco MP; Chen J; Wainer IW; Ducharme MP
    Ther Drug Monit; 2004 Aug; 26(4):401-7. PubMed ID: 15257070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.
    Forrest A; Ballow CH; Nix DE; Birmingham MC; Schentag JJ
    Antimicrob Agents Chemother; 1993 May; 37(5):1065-72. PubMed ID: 8517693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections.
    Payen S; Serreau R; Munck A; Aujard Y; Aigrain Y; Bressolle F; Jacqz-Aigrain E
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3170-8. PubMed ID: 14506027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of high-pressure liquid chromatography and microbiological assay for determination of ciprofloxacin tablets in human plasma employed in bioequivalence and pharmacokinetics study.
    Khan MK; Khan MF; Mustafa G; Sualah M
    Pak J Pharm Sci; 2012 Jan; 25(1):81-8. PubMed ID: 22186313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.
    Leroux S; Turner MA; Guellec CB; Hill H; van den Anker JN; Kearns GL; Jacqz-Aigrain E; Zhao W;
    Clin Pharmacokinet; 2015 Dec; 54(12):1273-85. PubMed ID: 26063050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.
    Fabre D; Bressolle F; Gomeni R; Arich C; Lemesle F; Beziau H; Galtier M
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2521-5. PubMed ID: 1810184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of ciprofloxacin pharmacokinetics in children: impact on dose range in sickle cell patients.
    Facchin A; Bui S; Leroux S; Nacka F; Koehl B; Maksoud E; Fayon M; Jacqz-Aigrain E;
    J Antimicrob Chemother; 2018 Dec; 73(12):3423-3429. PubMed ID: 30203024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic modeling to establish the role of P-glycoprotein on ciprofloxacin distribution to lung and prostate following intravenous and intratracheal administration to Wistar rats.
    Zimmermann ES; de Miranda Silva C; Neris C; Torres BGDS; Schmidt S; Dalla Costa T
    Eur J Pharm Sci; 2019 Jan; 127():319-329. PubMed ID: 30423435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX; Jiang ZG; Ding HZ; Liu YH
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program.
    Drusano GL; Liu W; Perkins R; Madu A; Madu C; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1683-7. PubMed ID: 7486900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
    Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
    J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    Chest; 2001 Apr; 119(4):1114-22. PubMed ID: 11296178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
    Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
    Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
    Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P; Gastonguay MR
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.